“…To evaluate the hypothesis that PLEV and/or EYYV could modulate FGF14:Nav1.6 complex assembly, an in-cell assay was used with a HEK293 cell line (hereafter coded as "Clone V" cells) stably expressing both CLuc-FGF14 and CD4-Nav1.6-NLuc (Shavkunov et al, 2012;Shavkunov et al, 2013;Shavkunov et al, 2015;Ali et al, 2016Ali et al, , 2018Wadsworth et al, 2019Wadsworth et al, , 2020Dvorak et al, 2020Dvorak et al, , 2021Singh et al, 2020;Wang et al, 2020). In this assay, upon binding of FGF14 to the Nav1.6 C-terminal tail, there is reconstitution of the NLuc and CLuc halves of the luciferase enzyme, which produces luminescence in the presence of substrate D-luciferin (Figures 2A,D).…”